The A-share traditional Chinese medicine sector saw a surge, with Panlong Pharmaceutical hitting the daily limit, followed by gains in Enwei Pharmaceutical, Longshen Rongfa, Datang Pharmaceutical, Zhongheng Group, and Sanli Pharmaceutical.

2026-11-09

The A-share traditional Chinese medicine sector saw a surge, with Panlong Pharmaceutical hitting the daily limit, followed by gains in Enwei Pharmaceutical, Longshen Rongfa, Datang Pharmaceutical, Zhongheng Group, and Sanli Pharmaceutical.

Other News
2026-11-09

At the open in China’s A-share market, the Shanghai Composite rose 0.27%, the Shenzhen Composite Index gained 0.87% and the ChiNext Index advanced 1.19%. Semiconductors, industrial gases and precious metals led gains.

2026-11-08

CITIC Securities in its 2027 telecom strategy report says large-model commercialization expands rapidly in 2026; as of end‑September 2026 OpenAI and Anthropic had combined ARR of about $124 bln. North America’s four major cloud service providers repo